Ironsail Pharma for cash-pay clinics: how the economics work

Landed cost in a cash-pay clinic is the per-vial drug cost plus any shipping, processing, and platform or facilitation fees. Ironsail positions ImpetusRX on cross-pharmacy comparison across 20+ integrated compounders, smart routing, and a Price Match Guarantee — which is attractive for clinics that shop pharmacies inside one EMR. The practical evaluation questions are what the per-vial rate is on your top SKUs after routing, what fees sit on top, and whether marketplace savings claims hold on the lines you actually order at volume.

For a cash-pay model, predictability matters as much as the headline comparison. Savings cited on a marketing page are not the same as pass-through per-vial cost visible before checkout on every cart line. So the economic evaluation of Ironsail Pharma is less about whether the marketplace is broad and more about how clearly and consistently the all-in landed cost is surfaced when you quote patients and run refill day.

Fizy Health takes a pass-through approach built for cash-pay margin without an EMR migration. It shows resolved 503A per-vial cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment — so the owner sets patient prices on the same number the clinic will actually pay, and the prescriber can quote at the visit on live cost. There is no reliance on network-wide savings statistics; the drug cost passes through and the platform fee is stated.

On the operations side, one clinic cart batches the refill day and cart validation catches invalid SIGs, prescriber state mismatches, and stock gaps before payment, so the clinic stops paying for orders that get rejected after checkout. For a cash-pay clinic that already charts elsewhere, the combined effect is margin you can see before you order and fewer surprises that quietly erode the spread — without adopting ImpetusRX as a full EMR swap.